Gsk (GSK) Net Margin (2009 - 2026)
Gsk (GSK) posted quarterly Net Margin of 5.17% for Q2 2026, down 1290.0% year-over-year from 0.43% in Q2 2025, and down 77.28% quarter-over-quarter from 22.77% in Q1 2026.
Gsk (GSK) Net Margin (2009 - 2026) Analysis & Trends
Gsk's Net Margin history runs 18 years deep, the most recent figure standing at 5.17% for Q2 2026.
- In Q2 2026, Net Margin fell 1290.0% year-over-year to 5.17%; the TTM figure through Jun 2026 stood at 18.1% (up 464.0% YoY), while the FY2025 annual figure was 17.5%, up 929.0% from the prior year.
- Net Margin for Q2 2026 stood at 5.17%, down from 22.77% in the prior quarter.
- The five-year high for Net Margin was 138.22% in Q3 2022, with the low at 0.72% in Q3 2024.
- The 5-year median for Net Margin is 20.61% (2023), against an average of 28.85%.
- The sharpest annual moves came in 2022 and 2023: Net Margin soared 12059 bps in 2022, then tumbled 12025 bps in 2023.
- Gsk's Net Margin stood at 105.93% in 2022, then tumbled by 79 bps to 22.04% in 2023, then tumbled by 34 bps to 14.55% in 2024, then surged by 36 bps to 19.78% in 2025, then slumped by 74 bps to 5.17% in 2026.
- Business Quant data shows GSK's Net Margin at 5.17% in Q2 2026, 22.77% in Q1 2026, and 19.78% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.03 Bn | 634.27 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.29 Bn | 463.72 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 380.80 Bn | 373.66 Bn | 12.21 Bn | -8.05% |
| 4 | Novartis Ag | 302.80 Bn | 295.11 Bn | 11.24 Bn | 22.65% |
| 5 | Astrazeneca | 258.24 Bn | 253.34 Bn | 12.86 Bn | 16.30% |
| 6 | Amgen | 237.40 Bn | 223.41 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 183.07 Bn | 179.89 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 161.54 Bn | 149.84 Bn | 10.94 Bn | -1.58% |
| 9 | Gsk | 106.01 Bn | 101.85 Bn | 8.24 Bn | 5.17% |
| 10 | Sanofi | 55.05 Bn | 47.67 Bn | 10.79 Bn | 2.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.17% |
| Mar 31, 2026 | 22.77% |
| Dec 31, 2025 | 19.78% |
| Sep 30, 2025 | 23.55% |
| Jun 30, 2025 | 18.07% |
| Mar 31, 2025 | 21.61% |
| Dec 31, 2024 | 14.55% |
| Sep 30, 2024 | -0.72% |
| Jun 30, 2024 | 14.88% |
| Mar 31, 2024 | 14.21% |
| Dec 31, 2023 | 22.04% |
| Sep 30, 2023 | 17.97% |
| Jun 30, 2023 | 22.62% |
| Mar 31, 2023 | 21.44% |
| Dec 31, 2022 | 105.93% |
| Sep 30, 2022 | 138.22% |
| Jun 30, 2022 | 12.09% |
| Mar 31, 2022 | 25.06% |
| Dec 31, 2021 | 9.99% |
| Sep 30, 2021 | 17.62% |